Lipidor Ab (Sweden) Performance
| LIPI Stock | SEK 0.32 0.03 10.34% |
Lipidor Ab holds a performance score of 20 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -1.11, which conveys a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Lipidor Ab are expected to decrease slowly. On the other hand, during market turmoil, Lipidor Ab is expected to outperform it slightly. Use Lipidor Ab total risk alpha, treynor ratio, value at risk, as well as the relationship between the sortino ratio and maximum drawdown , to analyze future returns on Lipidor Ab.
Risk-Adjusted Performance
20 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Lipidor Ab are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Lipidor Ab unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 64.3 M | |
| Total Cashflows From Investing Activities | -774 K |
Lipidor |
Lipidor Ab Relative Risk vs. Return Landscape
If you would invest 15.00 in Lipidor Ab on October 12, 2024 and sell it today you would earn a total of 17.00 from holding Lipidor Ab or generate 113.33% return on investment over 90 days. Lipidor Ab is generating 1.4651% of daily returns and assumes 5.6533% volatility on return distribution over the 90 days horizon. Simply put, 50% of stocks are less volatile than Lipidor, and 71% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Lipidor Ab Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lipidor Ab's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Lipidor Ab, and traders can use it to determine the average amount a Lipidor Ab's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2592
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | LIPI | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.65 actual daily | 50 50% of assets are less volatile |
Expected Return
| 1.47 actual daily | 29 71% of assets have higher returns |
Risk-Adjusted Return
| 0.26 actual daily | 20 80% of assets perform better |
Based on monthly moving average Lipidor Ab is performing at about 20% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lipidor Ab by adding it to a well-diversified portfolio.
Lipidor Ab Fundamentals Growth
Lipidor Stock prices reflect investors' perceptions of the future prospects and financial health of Lipidor Ab, and Lipidor Ab fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lipidor Stock performance.
| Return On Equity | -1.35 | |||
| Return On Asset | -0.64 | |||
| Operating Margin | (182.51) % | |||
| Current Valuation | 217.62 M | |||
| Shares Outstanding | 28.98 M | |||
| Price To Book | 10.59 X | |||
| Price To Sales | 67.35 X | |||
| Revenue | 15.38 M | |||
| EBITDA | (21.09 M) | |||
| Cash And Equivalents | 53.13 M | |||
| Cash Per Share | 1.87 X | |||
| Book Value Per Share | 0.40 X | |||
| Cash Flow From Operations | (13.38 M) | |||
| Earnings Per Share | (0.98) X | |||
| Total Asset | 55.02 M | |||
About Lipidor Ab Performance
Assessing Lipidor Ab's fundamental ratios provides investors with valuable insights into Lipidor Ab's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Lipidor Ab is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Lipidor AB , a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, bacterial skin infections, and atopic dermatitis. Lipidor AB was founded in 2009 and is based in Stockholm, Sweden. Lipidor AB is traded on Stockholm Stock Exchange in Sweden.Things to note about Lipidor Ab performance evaluation
Checking the ongoing alerts about Lipidor Ab for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Lipidor Ab help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lipidor Ab is way too risky over 90 days horizon | |
| Lipidor Ab has some characteristics of a very speculative penny stock | |
| Lipidor Ab appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 15.38 M. Net Loss for the year was (21.29 M) with loss before overhead, payroll, taxes, and interest of (12.66 M). | |
| Lipidor Ab has accumulated about 53.13 M in cash with (13.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 49.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Lipidor Ab's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lipidor Ab's stock is overvalued or undervalued compared to its peers.
- Examining Lipidor Ab's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lipidor Ab's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lipidor Ab's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lipidor Ab's stock. These opinions can provide insight into Lipidor Ab's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Lipidor Stock Analysis
When running Lipidor Ab's price analysis, check to measure Lipidor Ab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipidor Ab is operating at the current time. Most of Lipidor Ab's value examination focuses on studying past and present price action to predict the probability of Lipidor Ab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipidor Ab's price. Additionally, you may evaluate how the addition of Lipidor Ab to your portfolios can decrease your overall portfolio volatility.